ArticleMultiple sclerosis and related disorders2021

Patient-reported safety and tolerability of the COVID-19 vaccines in persons with rare neuroimmunological diseases.

Itay Lotan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.